Otros idiomas Edwards Lifesciences Corporation Xetra

Acciones

EWL

US28176E1082

Tiempo real estimado Tradegate Otros sitios de cotización 13:23:36 14/06/2024			Varia. Cinco días.	Varia. 1 de enero.
81,22 ^EUR	+0,23 %		+0,87 %	+17,06 %

05/06	Edwards Lifesciences anuncia los resultados del análisis de los datos de los ensayos PARTNER que examinan los resultados de los pacientes de sustitución percutánea de la válvula aórtica con anillo pequeño	CI
05/06	Transcript : Edwards Lifesciences Corporation Presents at Jefferies 2024 Global Healthcare Conference, Jun-05-2024 10:30 AM

Otros idiomas

Desbloquee todas las noticias: ¡Sea el primero en enterarse y reaccione antes que los mercados!

Inscripción 100% Gratuita

Five-Year Data Show Excellent Outcomes for Female and Small Annulus Patients With Edwards TAVR	05/06
Edwards Lifesciences Announces Results from Analysis of Data from Partner Trials Examining Outcomes of Transcatheter Aortic Valve Replacement Patients with Small Annulus	05/06
Sector Update: Health Care Stocks Steady Premarket Monday	03/06
Edwards Lifesciences : Autodesk, Gamestop, Nvidia... les valeurs à suivre aujourd'hui à Wall Street -	03/06
Edwards Lifesciences : cède sa filiale soins intensifs à Becton Dickison	03/06
Becton, Dickinson to Acquire Edwards Lifesciences' Critical Care Product Division for $4.2 Billion in Cash	03/06
Edwards Lifesciences to sell critical care products unit to Becton Dickinson for $4.2 bln	03/06
Becton, Dickinson to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2 Billion	03/06
BD to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2 Billion to Expand Smart Connected Care Solutions and Become an Advanced Monitoring Technology Leader	03/06
Edwards Lifesciences to Sell Critical Care to BD	03/06
Becton, Dickinson and Company entered into an agreement to acquire Critical Care Product Group of Edwards Lifesciences Corporation (NYSE : EW) for $4.2 billion.	03/06
Edwards Lifesciences : Charter of the Audit Committee	28/05
Some of the biggest splits in Corporate America	23/05
Edwards Lifesciences : First Quarter 2024 Fact Sheet	15/05
Edwards Lifesciences Insider Sold Shares Worth $439,038, According to a Recent SEC Filing	13/05
Edwards Lifesciences Faces EU Antitrust Complaint By Meril	13/05
Edwards Lifesciences hit with Meril's EU antitrust complaint	13/05
Edwards stellt Herzklappenmodell SAPIEN 3 Ultra RESILIA mit Technologie für verbesserte Haltbarkeit in Europa vor	09/05
Edwards lance la valve SAPIEN 3 Ultra RESILIA en Europe avec une technologie pour améliorer la durabilité	09/05
Edwards Launches the SAPIEN 3 Ultra RESILIA Valve in Europe With Technology to Enhance Durability	09/05

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Titulares

Edwards Lifesciences Corporation : La historia continúa

23 de abril 2024 a las 16:35